Accelerating TB vaccine Research & Development through partnership
TuBerculosis Vaccine Initiative (TBVI) is dedicated to accelerating TB vaccine research and development through strategic partnerships. Located at Runderweg 6, 8219 PK Lelystad, NL, TBVI operates as a non-profit foundation, integrating and prioritizing research and development efforts to discover new TB vaccines and biomarkers for global use.
TBVI provides essential services to support the R&D efforts of its consortium partners, which include project identification, design, and development, project management, resource mobilization, knowledge development, exchange, and networking, and technical advice and support for product and clinical development. TBVI’s commitment extends to ensuring the accessibility and affordability of TB vaccines for the developing world, making it a statutory objective of the organization.
TuBerculosis Vaccine Initiative (TBVI) innovates and diversifies the pipeline for TB vaccines and accelerates the most promising vaccine and biomarker candidates. The organization seeks to align its portfolio management approach with other global efforts. We invite the management of TuBerculosis Vaccine Initiative (TBVI) to create a customized and exclusive company showcase and product listing on our platform.
Compare TuBerculosis Vaccine Initiative (TBVI) with 3 companies in Research-Services
| Comparison Field |
Tu
TuBerculosis Vaccine Init...Main Company |
Elizabeth Glaser Ped...View Profile |
Gavi, the Vaccine Al...View Profile |
Asian Liver Center a...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1988 | 2000 | 1996 |
|
Company Size
|
— | 1,001-5,000 | 201-500 | 11-50 |
|
City
|
Washington, District of Columbia | Le Grand-Saconnex, Geneva | Palo Alto, CA | |
|
Country
|
United States | Switzerland | United States | |
|
Skills & Keywords
Comparing with main company
|
13 Total Skills
Tuberculosis vaccines
Vaccine research
Global health
Immunization
Biomarker discovery
Product development partnership
TBVI
tuberculosis
vaccines
advocacy
immunisation
research
global health
|
2 Total
2 Unique
Unique Skills:
program implementation
technical assistance
|
5 Total
5 Unique
Unique Skills:
#VaccinesWork
COVID-19
international development
public health
public private partnership
|
10 Total
10 Unique
Unique Skills:
cancer research
collaboration
community health
community outreach
hepatitis B
liver cancer
+4
|
Other organizations in the same industry
This company is also known as